Le pubblicazioni
2025
- Masini G, Barsacchi M, Chiusolo S, Alberti M, Gargani L, Corradi F, De Caterina R.
Iron Deficiency in Acute Coronary Syndromes-Clinical Correlates and Outcomes.
- Pieroni I, Cerroni G, Velluto L, Sorbi S, Guarnieri B.
Sex and age differences in sleep disorders: insights from a diverse cohort referred to a sleep center.
- Morrone D, Dinshaw L, de Souza JAG, Chen C, Kirchhof P, Koretsune Y, Pecen L,
Wang CC, Yamashita T, Unverdorben M, De Caterina R.
Edoxaban treatment in routine clinical practice is highly concordant with the 2020 European Society of Cardiology atrial fibrillation guidelines: results from the noninterventional Global ETNA-AF programme.
- De Caterina R, Unverdorben M, Chen C, Choi EK, Koretsune Y, Morrone D, Pecen L, Bramlage P, Wang CC, Yamashita T, Kirchhof P.
2024
- Grimaldi S, Migliorini P, Puxeddu I, Rossini R, De Caterina R.
Aspirin hypersensitivity: a practical guide for cardiologists.
- Zoccali C, Mallamaci F, Halimi JM, Rossignol P, Sarafidis P, De Caterina R, Giugliano R, Zannad F.
From Cardiorenal Syndrome to Chronic Cardiovascular and
Kidney Disorder: A Conceptual Transition.
- Kirchhof P, Bakhai A, de Asmundis C, de Groot JR, Deharo JC, Kelly P, Lopez-
de-Sa E, Monteiro P, Fronk EM, Lamparter M, Laeis P, Smolnik R, Steffel J, Waltenberger J, Weiss TW, De Caterina R; ETNA-AF-Europe investigators.
Long-term
effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year data from the ETNA-AF-Europe study.
- Kim HS, Kang J, Stefanini G, De Caterina R.
Antiplatelet monotherapy after
DAPT: is clopidogrel the new standard? Pros and cons.
- Verburg A, Bor WL, Küçük IT, Henriques JPS, Vink MA, Ruifrok WT, Plomp J,
Heestermans TACM, Schotborgh CE, Vlaar PJ, Magro M, Rikken SAOF, van den Broek
WWA, van Mieghem CAG, Cornelis K, Rosseel L, Dujardin KS, Vandeloo B, Vandendriessche T, Ferdinande B, van ‘t Hof AWJ, Tijssen JGP, Limbruno U, De Caterina R, Rubboli A, Angiolillo DJ, Adriaenssens T, Dewilde W, Ten Berg JM.
Temporary omission of oral anticoagulation in atrial fibrillation patients
undergoing percutaneous coronary intervention: rationale and design of the
WOEST-3 randomised trial.
- Gwechenberger M, Barón-Esquivias G, de Vries TAC, Siller Matula JM, Manu MC,
Souza JAG, Wienerroither S, Pecen L, de Groot JR, De Caterina R, Kirchhof P;
ETNA-AF-Europe Investigators. Incidence and Predictors of Worsening Renal
Function in Edoxaban-Treated Atrial Fibrillation Patients Within ETNA-AF-Europe
Registry.
- Sadeghipour P, Mozafarybazargany M, Farrashi M, De Caterina R.
Response to “Characteristics of the prothrombotic milieu in mitral stenosis patients managed with direct oral anticoagulants”.
- Tamborrino PP, Papi L, Michelotti L, Vitale C, Caravelli P, Petronio AS, Terlizzi E, Della Volpe L, Virlan M, Sardanelli A, Morganti R, De Caterina R.
Do We Need Fasting Prior to Coronary Angiography? The CORO-NF Randomized Pragmatic Study.